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This study examined the effect of carbon dioxide, lidoflazine, and deferoxamine therapy upon 
the 10-day survival incidence and subsequent neurologic function of rats subjected to 7 min of 
cardiorespiratory arrest with resuscitation. Cardiac arrest (asystole) was induced at time zero by 
injection of cold, 1% KCl into the left ventricle of ketamine-anesthetized rats pretreated with 
succinylcholine. Positive pressure ventilation was discontinued at time zero. Cardiopulmonary 
resuscitation (CPR) was begun at 7 min, and animals with return of spontaneous circulation were 
entered into the study. Twenty treated rats were ventilated for 1 h with 7% carbon dioxide-93% 
oxygen and given lidoflazine (2.0 mg/kg, i.v.) and deferoxamine (50 mg/kg, i.v.) 5 min after 
CPR. Twenty control rats were ventilated for 1 h with 100% oxygen and given lidoflazine 
vehicle and deferoxamine vehicle. Lidoflazine treatment (1.0 mg/ kg) for the treated group, or 
lidoflazine vehicle for the control group, was repeated at 8 h postresuscitation. At 2 days 
postresuscitation, 75% of treated rats vs. 25% of control rats were alive (Chi-square = 10.0, d.f. = 
1, P < 0.01), and at 10 days, 60% of treated rats vs. 25% of control rats were alive (Chi-square = 
5.01, d.f. = 1, P < 0.05).  There was no detectable neurologic deficit among survivors in either 
group at 15 days. The combination of carbon dioxide, lidoflazine, and deferoxamine, 
administered after return of spontaneous circulation, is a simple and easily administered 
treatment regimen that improves the survival incidence without neurologic deficits in this animal 
model of cardiorespiratory arrest and CPR. 
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Modem methods of cardiopulmonary resuscitation and advanced cardiac life support can 
successfully restore spontaneous circulation in up to 56% of victims of prehospital cardiac arrest 
(DeBard, 1981). However, fewer than half of the initially resuscitated patients survive to leave 
the hospital (DeBard, 1981; Eisenberg et al., 1979; Myerburg et al., 1980). Central nervous 
system (CNS) damage and hemodynamic abnormalities have caused 59% and 31%, respectively, 
of postresuscitation, in-hospital deaths (Myerburg et al., 1980), and permanent functional 
neurologic disability is reported in 10%-40% of patients surviving prehospital cardiac arrest 
(Liberthson et al., 1974). In recent years, evidence has begun to accumulate to support the 
hypothesis that a significant fraction of the irreversible tissue injury observed after ischemia and 
reperfusion is actually caused during the reperfusion phase, and is therefore amenable to 
prevention or treatment by therapy administered after initially successful cardiac resuscitation, 
both in the emergency room and during subsequent hospitalization. 
 
Selected therapeutic interventions directed at one or more of the changes which have been 
postulated to occur after resuscitation from cardiac arrest, or have been shown in vitro to occur 
during reperfusion of ischemic tissue, may be a logical means of preventing or minimizing the 
adverse effects that occur during the postresuscitation period. In the present study, we evaluated 
the effectiveness of a simple and easily administered multi-modal therapy, including a cerebral 
vasodilator (carbon dioxide), a calcium entry blocker (lidoflazine), and an iron chelator 
(deferoxamine), intended to minimize reperfusion injury following total circulatory arrest and 
CPR in rats. All therapy was administered after return of spontaneous circulation in a clinically 
realistic time frame (DeGaravilla et al., 1984). 
 
 
MATERIALS AND METHODS 
 
Male Wistar rats, each weighing between 350 and 500 g, were utilized in this study. Following 
anesthesia with an intraperitoneal injection of ketamine (60 mg/kg) and neuromuscular blockade 
with succinylcholine (1.5 mg/ kg), cardiorespiratory arrest (asystole) was induced in each rat by 
a percutaneous intracardiac injection of 0.4-0.8 ml of a cold 1% KCI cardioplegic solution and 
digital compression of the thorax (DeGaravilla et al., 1984). Electrocardiograms were monitored 
throughout the arrest and immediate postresuscitation period. The cardiorespiratory arrest was 
maintained for 7 min. Resuscitation was accomplished by interposed abdominal compression-
cardiopulmonary resuscitation (IAC-CPR) (Voorhees et al., 1984) and jet ventilation at 70 
breaths/min with 7% carbon dioxide-93% oxygen (treated group) or with 100% oxygen (control 
group). The ventilatory gas used, and therefore the group entered, was alternated each time an 
animal was successfully resuscitated and entered into the study. Any variability in handling the 
animals and in the procedures used was effectively minimized in this fashion. This method of 
cardiorespiratory arrest and resuscitation was continued until 20 rats each were successfully 




Following 1-3 min of IAC-CPR, the return of a strong spontaneous apex heartbeat, and the return 
to sinus rhythm as documented by the electrocardiogram, the treated rats were given lidoflazine 
(2 mg/k.g) and deferoxamine (50 mg/kg) by slow intravenous infusion for a 15-min period. The 
control rats were given equivalent volumes of the vehicle for the lidoflazine solution (a dilute 
acetic acid solution, pH = 4.5) and the solvent for the deferoxamine (0.9% saline) by jugular 
intravenous infusion. Lidoflazine (1.0 mg/kg) was given to treated rats again at 8 h 
postresuscitation by intraperitoneal injection, and control rats received the lidoflazine vehicle. 
All rats were placed on a 37°C heating pad after resuscitation, and 5 ml each of 5% dextrose 
solution and lactated ringers solution were given by subcutaneous injection to maintain 
hydration. The ventilation frequency was gradually reduced to 20/min during the subsequent 120 
minutes and then discontinued when vigorous spontaneous respirations were observed. 
 
The rats were returned to individual cages following resuscitation and stabilization, and were 
observed daily. The number of animals surviving postresuscitation was recorded at 1 h, 12 h, 24 
h, and at daily intervals for 10 days. Chi-square statistics were calculated to test the null 
hypothesis that at each recording time the percentage of rats surviving in the control and treated 
groups was the same (Dunn, 1977). 
 
Neurologic deficits at 15 days postresuscitation were evaluated in each rat by applying a 
modification of the Safar neurologic scoring method for dogs (Safar et al., 1976). This method 
has been validated in numerous studies in this laboratory and has proven applicable to the rat 
model of cardiorespiratory arrest and resuscitation. All neurologic evaluations were done by the 
same individual and without knowledge of the treatment group to which the rat belonged. The 
specific tests and the corresponding point values are listed in Table I. A score of 0 represented no 






TABLE I. NEUROLOGIC DEFICIT SCORING CRITERIA 
 
Neurologic deficit scoring for rats: Normal rat = 0, brain death = 100.  








Eighty-four percent of the rats (20/24) in which 100% oxygen was the ventilatory gas (control 
group) were successfully resuscitated and entered in the study, and 77% of the rats (20/26) in 
which 93% carbon dioxide/7% oxygen was the ventilatory gas (treated group) were successfully 
resuscitated and entered into the study. Rats in the control group regained a spontaneous sinus 
rhythm and palpable heart beat in a mean time of 74 sec (range of 62-90 sec, median of 72 sec). 
Rats in the treated group regained a spontaneous sinus rhythm and palpable heart beat in a mean 
time of 76 sec (range of 60-83 sec, median of 69 sec). The percentage of rats surviving was 
significantly greater (Chi-square = 10.0, d.f. = 1, P < 0.01) in the treated group than the control 
group, 75% vs. 25% respectively, at 2 days postresuscitation (Fig. 1). The difference in survival 
between the 2 groups was maximum at 2 and 3 days postresuscitation. After 3 days, the 
difference in survival between the 2 groups remained relatively constant, and after 10 days 60% 
of the treated animals were alive and 25% of the control animals were alive (Chi-square = 5.0, 





Fig. 1. The sequential survival incidence of treated vs. control rats for 10 days 
following resuscitation from 7 min of cardiorespiratory arrest (n = 20 for each group). 
 
It should be noted that lidoflazine frequently caused bradycardia and a palpable diminution of the 
apex beat if given during less than a 15-min time span. Neurologic deficit scores were not 
different between the treated and control groups. The mean score for survivors in both the treated 
and control groups was 2 out of a possible 100 points. The ranges of scores for survivors in the 






Increased awareness of cardiopulmonary resuscitation techniques by the general public, and the 
development of community based emergency medical systems have increased the number of 
patients that survive an out-of-hospital cardiac arrest (Myerberg et al., 1980; Liberthson et al., 
1974). However, many of these patients either die within the early postresuscitation period or 
survive with major organ disability, especially CNS dysfunction (Liberthson et al., 1974; 
Schaeffer and Cobb, 1975). 
 
The rationale for utilizing carbon dioxide, lidoflazine and deferoxamine in the present study to 
treat ischemic injury was based upon our current understanding of the pathophysiology of this 
type of injury in various tissues, previous studies in our laboratory, and the known effects of 
these drugs in normal tissues. First, Ames' "no reflow phenomenon" (Ames et al., 1968), which 
describes postischemic cerebral hypoperfusion, has been well substantiated by others (Gadzinski 
et al., 1982; Rehncrona et al., 1979; Snyder et al., 1973). This phenomenon may be caused by 
progressively increased cerebral vascular resistance without changes in intracranial pressure or 
evidence of thrombosis (Gadzinski et al., 1982; Rehncrona et al., 1979; Drewes et al., 1973). 
Therefore, maintenance of cerebral blood flow during the reperfusion phase after cardiac arrest 
appears to be a limiting factor in cerebral recovery from ischemic injury. Carbon dioxide is an 
effective and physiologic cerebral vasodilator which may alleviate postresuscitation global 
hypoperfusion of the brain (Cook and James, 1981; Harper, 1969). 
 
Second, several lines of evidence strongly implicate calcium in the pathogenesis of postischemic 
injury in both neural and non-neural tissue (Katz and Reuter, 1979; Schaune et al., 1979; Farber 
et al., 1981; Raichle, 1983). Three separate, potentially cytotoxic events have been attributed to 
intracellular calcium accumulation during reperfusion: (1) spasm of vascular smooth muscle, (2) 
mitochondrial failure, and (3) activation of intracellular membrane phospholipases. Lidoflazine, 
a calcium entry blocker, may inhibit the vasospasm and the intracellular calcium overload that 
occur following ischemia and reperfusion (Daenen and Flameng, 1981). This drug and other 
calcium antagonists have been reported to decrease neurologic deficits and cardiac pathologic 
alterations in animals following resuscitation from cardiac arrest (Daenen and Flameng, 1981; 
Hoffmeister et al., 1979; White et al., 1982; Winegar et al., 1983). 
 
Finally, membrane lipid peroxidation by free radicals has been proposed as a major mechanism 
for reperfusion injury (Siesjo et al., 1980; Cooper et al., 1980; Watson et al., 1984). Iron-





) have been associated with the initiation of lipid peroxidation (Aust et 
al., 1982; Bucher et al., 1983; Sugioka et al., 1983). Anderson and Means have shown that iron 
and oxidative mechanisms are important factors in traumatic spinal cord injury in the cat 
(Anderson and Means, in press, 1986). Oxygen radicals have not been demonstrated in ischemic 
tissue however, and the status of intracellular protective mechanisms against free radicals has 
been the subject of conflicting reports (Siesjo et al., 1980; Cooper et al., 1980). Deferoxamine, a 
safe, clinically available iron binding agent, inhibits lipid peroxidation in vitro, and 
administration of this drug to rats following cardiopulmonary arrest has resulted in increased 




The improved survival incidence that we found in animals treated with carbon dioxide, 
lidoflazine, and deferoxamine suggests that one or more of the biologic changes induced by 
ischemia and reperfusion, and altered or inhibited by these drugs, is a critical determinant in the 
progression to irreversible tissue injury during reperfusion. The marked difference between the 
treated and control groups at 2 days postresuscitation suggests that a critical step in the 
progression to irreversible tissue injury occurred at this time and that our therapeutic intervention 
had a beneficial effect upon host survival. In addition, one may speculate that the continued 
death of rats in the treated group is due to progressive reperfusion injury that occurred in animals 
that would have succumbed early following resuscitation but were protected by the combination 
therapy. The reperfusion tissue damage in these animals then progressed to lethal levels as the 
effects of the discontinued therapy diminished. The blood pressure was not monitored in the rats 
during this study. Therefore, the potential effect upon survival of changes in this parameter 
following therapy cannot be addressed. 
 
The neurologic deficit evaluation showed that all surviving animals were grossly normal, 
indicating that the quality of survival among treated animals was no different than that among 
controls. In addition, this combination therapy does not prolong recovery nor have detectable 
adverse side effects in this animal model. No attempt was made in this study to delineate the 
individual effectiveness of each therapeutic agent. The observed effects may have been due to 
any one, or combination of more than one, of the therapeutic modalities. Therefore, a part of or 
all of the combination therapy consisting of a cerebral vasodilator, a calcium entry blocker, and 
an iron chelator represents a feasible means of protection from postresuscitation morbidity and 
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